CARIS MOLECULAR TUMOR BOARD REPORT
"CARIS MOLECULAR TUMOR BOARD REPORT" is an active registered trademark owned by Caris MPI, Inc.. Using a similar name for the same goods or services could expose you to infringement claims. Always check with an attorney before launching a brand in this space.
CARIS MOLECULAR TUMOR BOARD REPORT is registered to cover providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment.
Caris MPI, Inc. is a mid-size portfolio holder with active trademark management, with 28 trademark filings on record (9 currently active), spanning 14 years of filing activity.
This application represents a multi-class filing across 2 Nice Classes — suggesting a brand strategy that spans multiple product or service categories, filed in March 2026. The 2-class strategy is typical of brands that sell both a product and operate their own retail or digital channel.